Supercharge Your Innovation With Domain-Expert AI Agents!

Application of cycloastragenol in preparing medicine for treating psoriasis

A technology for cycloastragalus and psoriasis, which is applied in the application field of cycloastragalol in the preparation of medicines for treating psoriasis, can solve problems such as few studies, and achieve the effect of reducing skin thickening

Active Publication Date: 2019-06-28
NANJING UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Since the chemical structure of Cycloastragenol (CAG) was reported, there have been few studies on this compound, and there have been no reports about its pharmacological activity, especially the effect of treating diseases related to psoriasis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of cycloastragenol in preparing medicine for treating psoriasis
  • Application of cycloastragenol in preparing medicine for treating psoriasis
  • Application of cycloastragenol in preparing medicine for treating psoriasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] 1. Pharmacological experiment of cycloastragenol

[0028] Imiquimod-induced mouse psoriasis model [1]

[0029] C57BL / 6 female mice, aged 6-8 weeks, weighing 18-22 grams, were raised in an SPF animal room at 21±2°C, free to drink and eat, and alternate day and night for 12 hours. After the mouse was anesthetized with 1% pentobarbital sodium, the hair on the back of the mouse was shaved in an area of ​​about 2 cm×2 cm to expose the back skin. Two days later, mice were randomly divided into 6 groups, normal group (Sham group), model group (Imiquimod, IMQ group), cycloastragenol (Cycloastragenol, CAG) low, medium and high dose groups (12.5mg / kg, 25mg / kg, 50mg / kg), andrographolide group (Andrographolide, Andro group, 10mg / kg). The normal group and the model group were given the same amount of PBS, and the other groups were intragastrically administered according to the dosage, once a day, 0.1ml each time. Except for the normal group, the other groups evenly applied imiq...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to new application of cycloastragenol, in particular to application of cycloastragenol in preparing medicine for treating psoriasis. Cycloastragenol can effectively improve skinthickening and inflammatory factor infiltration of a lesion skin part. For a psoriasis model mouse induced by imiquimod, the cycloastragenol can remarkably improve the skin thickening condition of thelesion part, and meanwhile the dosage can independently lower the level of the inflammatory factor wetted in the lesion part skin.

Description

technical field [0001] The present invention relates to the new use of cycloastragenol, in particular to the application of cycloastragenol in the preparation of medicines for treating psoriasis Background technique [0002] Since the chemical structure of Cycloastragenol (CAG) was reported, there has been little research on this compound, and there has been no report on its pharmacological activity, especially the effect on treating diseases related to psoriasis. The present invention mainly finds that cycloastragenol has a significant improvement effect on psoriasis models. [0003] Cycloastragenol (Cycloastragenol, CAG), its structural formula is as follows: [0004] Contents of the invention [0005] The role of cycloastragenol in the preparation of drugs for the treatment of psoriasis. [0006] Specifically: [0007] 1. Pharmacological experiment of cycloastragenol [0008] Imiquimod-induced psoriasis model in mice [1] [0009] C57BL / 6 female mice, aged 6-8 w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/58A61P17/06
Inventor 孙洋徐强顾正兵邓国亮朱雨雨
Owner NANJING UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com